UB Paderborn / Katalog / Suche / in CDI

1 – 13 von 13

Sortiert nach

Use of Efavirenz Is Not Associated with a Higher Risk of Depressive Disorders: A Substudy of the Randomized Clinical Trial ALIZE-ANRS 099

Clinical infectious diseases, 2006-06, Vol.42 (12), p.1790-1799

2006

Volltextzugriff (PDF)

Role of Long-Term Nucleoside-Analogue Therapy in Lipodystrophy and Metabolic Disorders in Human Immunodeficiency Virus—Infected Patients

Clinical infectious diseases, 2002-03, Vol.34 (5), p.649-657

2002

Volltextzugriff (PDF)

Simplification Therapy with Once-Daily Emtricitabine, Didanosine, and Efavirenz in HIV-1–Infected Adults with Viral Suppression Receiving a Protease Inhibitor–Based Regimen: A Randomized Trial

The Journal of infectious diseases, 2005-03, Vol.191 (6), p.830-839

2005

Volltextzugriff (PDF)

Once-Daily Combination Therapy with Emtricitabine, Didanosine, and Efavirenz in Human Immunodeficiency Virus—Infected Patients

The Journal of infectious diseases, 2000-08, Vol.182 (2), p.599-602

2000

Volltextzugriff (PDF)

Is hepatitis C virus co-infection associated with survival in HIV-infected patients treated by combination antiretroviral therapy?

AIDS (London), 2002-07, Vol.16 (10), p.1357-1362

2002

Volltextzugriff (PDF)

The ALBI Trial: A Randomized Controlled Trial Comparing Stavudine Plus Didanosine with Zidovudine Plus Lamivudine and a Regimen Alternating Both Combinations in Previously Untreated Patients Infected with Human Immunodeficiency Virus

The Journal of infectious diseases, 1999-08, Vol.180 (2), p.351-358

1999

Volltextzugriff (PDF)

About the necessity to manage events coded with MedDRA prior to statistical analysis: Proposal of a strategy with application to a randomized clinical trial, ANRS 099 ALIZE

Contemporary clinical trials, 2008-03, Vol.29 (2), p.95-101

2008

Volltextzugriff (PDF)

Simplification Therapy with Once-Daily Emtricitabine, Didanosine, and Efavirenz in HIV-1-Infected Adults with Viral Suppression Receiving a Protease Inhibitor-Based Regimen: A Randomized Tria

The Journal of infectious diseases, 2005-03, Vol.191 (6), p.830-839

2005

Volltextzugriff (PDF)

Simplification therapy with once-daily emtricitabine, didanosine, and efavirenz in HN-1-infected adults with viral suppression receiving a protease inhibitor-based regimen : A randomized trial

The Journal of infectious diseases, 2005, Vol.191 (6), p.830-839

2005

Volltextzugriff (PDF)

IgE serum level: A prognostic marker for AIDS in HIV-infected adults?

Journal of allergy and clinical immunology, 1998-08, Vol.102 (2), p.329-330

1998

Volltextzugriff (PDF)

Five-year follow up of once-daily therapy with emtricitabine, didanosine and efavirenz (Montana ANRS 091 trial)

Antiviral therapy, 2007-01, Vol.12 (3), p.417-422

2007

Volltextzugriff (PDF)

What hides behind an intention‐to‐treat analysis?

Hepatology (Baltimore, Md.), 2001-04, Vol.33 (4), p.1014-1014

2001

Volltextzugriff (PDF)

Analysis of Undetectable HIV RNA Using Survival Analysis: Results Must Be Interpreted Carefully

HIV clinical trials, 2003-11, Vol.4 (6), p.417-420

2003

Volltextzugriff (PDF)

1 – 13 von 13

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(12)
Mit Volltextzugriff
(12)

Publikationsform

Artikel
(13)

Sprache

Englisch
(13)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Use of Efavirenz Is Not Associated with a Higher Risk of Depressive Disorders: A Substudy of the Randomized Clinical Trial ALIZE-ANRS 099

Role of Long-Term Nucleoside-Analogue Therapy in Lipodystrophy and Metabolic Disorders in Human Immunodeficiency Virus—Infected Patients

Simplification Therapy with Once-Daily Emtricitabine, Didanosine, and Efavirenz in HIV-1–Infected Adults with Viral Suppression Receiving a Protease Inhibitor–Based Regimen: A Randomized Trial

Once-Daily Combination Therapy with Emtricitabine, Didanosine, and Efavirenz in Human Immunodeficiency Virus—Infected Patients

Is hepatitis C virus co-infection associated with survival in HIV-infected patients treated by combination antiretroviral therapy?

The ALBI Trial: A Randomized Controlled Trial Comparing Stavudine Plus Didanosine with Zidovudine Plus Lamivudine and a Regimen Alternating Both Combinations in Previously Untreated Patients Infected with Human Immunodeficiency Virus

About the necessity to manage events coded with MedDRA prior to statistical analysis: Proposal of a strategy with application to a randomized clinical trial, ANRS 099 ALIZE

Simplification Therapy with Once-Daily Emtricitabine, Didanosine, and Efavirenz in HIV-1-Infected Adults with Viral Suppression Receiving a Protease Inhibitor-Based Regimen: A Randomized Tria

Simplification therapy with once-daily emtricitabine, didanosine, and efavirenz in HN-1-infected adults with viral suppression receiving a protease inhibitor-based regimen : A randomized trial

IgE serum level: A prognostic marker for AIDS in HIV-infected adults?

Five-year follow up of once-daily therapy with emtricitabine, didanosine and efavirenz (Montana ANRS 091 trial)

What hides behind an intention‐to‐treat analysis?

Analysis of Undetectable HIV RNA Using Survival Analysis: Results Must Be Interpreted Carefully

Suchergebnisse filtern